Objective: To observe the clinical effect of Shengxue Mixture (SXM) in treating aplastic anemia and study the possible mechanism. Methods: Eighty-four patients in the treated group with Spleen-Kidney Yang deficiency syndrome and Spleen-Kidney Yin deficiency syndrome were treated with SXM-Ⅰ and SXM-Ⅱ respectively, and 30 patients in the control group were treated with Stanozolol. The clinical effect and several experimental parameters were also observed. Results: The basic cure was gained in 18 cases, remission in 23, markedly improved in 32, ineffective 11, total effective rate and cure remission rate of the treated group were 86.90% and 48.81% respectively, which were obviously better than those of the control group (P<0.05) with no obvious side-effect. While the patient's symptoms were alleviated, the peripheral blood cells increased, the ratio of T lymphocyte subsets tended to balance, the level of natural killer cell activity increased, interleukin-2 reduced, and reproduction of the bone marrow were markedly improved in most of the patients treated by SXM. Conclusions: SXM is an effective and safe drug for aplastic anemia. Its mechanism might be likely due to its regulating the immune function, which facilitates the recovery of the bone marrow hematopoiesis function.

消化道肿瘤-T-术后早期肠内营养疗效研究

目的评价消化道肿瘤手术后早期肠内营养的安全性,比较手术后短期应用要素制剂爱伦多的肠内营养与标准肠外营养支持的疗效.方法62例消化道恶性肿瘤手术患者,随机分为对照组、肠外营养组和肠内营养组.手术后第一天开始等热卡、等氮量的肠外或肠内营养支持一周.检测体重、机体测量指标、血浆各内脏蛋白浓度及氮平衡等营养指标,外周血T细胞亚群、NK细胞和NK细胞活性等免疫指标及血清氨基酸谱.结果三组病人术后体重下降分别为4.26±1.03ks、2.04±0.65ke和2.12±o.72kg,对照组与肠外营养组、肠内营养组之间差异有显著性(P<0.05),后两组之间无差异.术后各内脏蛋白浓度均低于术前,对照组降低明显,与肠外或肠内营养组之间差异有显著性(P<0.05),而后两组之间无差异.三组病人平均氮平衡为-8.6±3.12g/d,-4.22±2.02g/d及-3.88±2.35g/d,对照组与肠外或肠内营养组之间差异有显著性(P<0.05),而后两组之间无差异.手术后各组病人外周血T细胞亚群、NK细胞和NK细胞活性均不同程度下降,但三组之间差异无显著性意义.三组病人血清谷氨酰胺水平明显下降,术后1周对照组和肠外营养组血清谷氨酰胺水平仍处于低水平,而肠内营养组却有一定程度恢复.结论消化道肿瘤手术后早期肠内营养支持是安全、有效的方法,短期肠内营养和肠外营养支持的临床效果基本相同.

Objective:To explore the effect of acitretin in combined with NB-UVB on T lymphocyte subsets in the peripheral blood in patients with psoriasis vulgaris.Methods:A total of 90 patients with psoriasis vulgaris who were admitted in our department from May, 2013 to May, 2015 were included in the study and randomized into the observation group and the control group. The patients in the control group were given acitretin after dinner, 10 mg/time, twice each day, for 6 weeks. The patients in the observation group were given acitretin in combined with UVB, each irradiation for 30 min, three times every week, for 6 weeks. The changes of CD3+, CD4+, and CD8+ in the peripheral blood, PASI score, and the clinical efficacy before and after treatment in the two groups were observed.Results:The elevation degree of CD3+ and CD4+ after treatment in the observation group was significantly obvious that in the control group, while the declining degree of CD8+ was also significantly obvious that in the control group. The decreased degree of PASI score after treatment in the observation group was significantly superior to that in the control group. The total effective rate in the observation group (93.33%) was significantly superior to that in the control group (80.00%).Conclusions:Acitretin in combined with UVB in the treatment of psoriasis vulgaris can play its role by altering the imbalance state of T lymphocyte immune function. The combined treatment can enhance the therapeutic effect, therefore, it deserves to be widely recommended in the clinic.